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Abstract 
Pulmonary artery embolism (PE) is a rare and life-threatening complication in the neonate.  We 
describe two previously stable infants who incurred respiratory failure from PE.  The first case is 
a late preterm infant with gastroschisis with autopsy confirmation of PE presumably as a result 
of a central venous line (CVL) with thromboembolism. The second case is an extreme low birth 
weight infant with sudden onset of respiratory failure, abnormal chest x-ray, disseminated 
intravascular coagulation (DIC), and echocardiographic confirmation of a thrombus at the 
junction of the superior vena cava and right atrium (SVC/RA) at the site of a previous CVL.  
This infant was successfully managed with thrombolytic therapy and anticoagulation.  We 
suggest that PE be considered in an infant with a history of a CVL who presents with otherwise 
unexplained respiratory failure.   
 
Introduction 
Neonatal thrombosis occurs in 5.1 per 100,000 births [1] and 2.4 per 1000 admissions to the 
neonatal intensive care unit.[2]  Excluding renal vein thrombosis, 45% of cases are arterial.[2]  PE 
occurs in 0.86 per 10,000 hospitalized children age one month to 18 years.[3] 
This report describes the clinical aspects of two previously stable premature infants with acute 
onset of respiratory failure from confirmed or suspected PE.  One case has autopsy confirmed 
massive PE with a suspected source of a femoral venous line with venous thrombosis, and the 
other has presumed PE with echocardiographic evidence of a thrombus located at the junction of 
the SVC/RA, the site of a previous CVL. 
We present these two cases to add to the body of literature on the clinical presentation of PE in 
the neonate and describe the successful medical treatment in one case. 
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Case One 
A 2070 gram female with gastroschisis and colonic atresia was delivered at our hospital at 34 
weeks by dates.  After fluid resuscitation, a surgical repair was undertaken.  A peripherally 
inserted central catheter (PICC) was placed for parenteral alimentation on the first day of life. On 
day of life 14 the PICC was replaced with a right femoral venous catheter.  On day of life 39 the 
infant developed staphylococcus epidermidis sepsis treated with vancomycin through the central 
line.  Doppler ultrasound of the interior vena cave (IVC), SVC, jugular and subclavian veins 
showed no thrombus; however, the IVC and SVC were poorly visualized.  On day of life 44 a 
left femoral venous catheter was placed.  On day of life 45 swelling and bluish discoloration of 
the left leg were noted.  Superficial veins on the abdominal wall were also more prominent.  The 
femoral line was functioning well with good blood return.  X-rays of the left hip and thigh were 
negative for fracture or osteomyelitis.  Repeat doppler ultrasound of the iliofemoral veins and 
IVC showed no venous thrombus. The edema improved over the next twelve hours.  Platelet 
counts ranged from 115,000-190,000.  On day of life 50 the infant suddenly developed 
hypotension, hypoxemia, and bradycardia.  The infant failed to respond to resuscitation and was 
pronounced dead.  At autopsy the contents of the pulmonary artery showed an organized 
thrombus (Figure 1) characterized by red cells, layering fibrin, and inflammatory cells.  
 
Figure 1.  Cross-section through the pulmonary artery containing an organized, fibrous clot. 
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Figure 2. A peripheral lung vessel with an organized thrombus including fibrin and inflammatory cells. 
 
Examination of the lungs revealed multiple microscopic emboli (Figure 2). No thrombophilia 
work-up was performed.   
 
Case Two 
A 740 gram female was delivered at our hospital at 26 weeks gestation by emergency cesarean 
section for abruptio placentae.  The infant was initially managed with nasal intermittent positive 
pressure ventilation and was weaned to room air on day of life 4.  No umbilical line was used.  A 
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PICC was placed on the second day of life and was discontinued on day of life 14 when full 
enteral feedings were achieved.  On day of life 16 the infant developed episodes of apnea and 
bradycardia requiring intubation and mechanical ventilation.  No blood or milk was noted from 
the endotracheal tube.  Chest x-ray showed diffuse bilateral pulmonary infiltrates.  Because of 
worsening hypoxia, inhaled nitric oxide (iNO) was begun.  CBC showed a white blood cell count 
of 4800 and evidence of DIC (platelet count 25,000, PT and PTT prolonged, D-dimer elevated). 
Platelets, fresh frozen plasma, and intravenous immune globulin were given.  There was no fall 
in hematocrit, an echocardiogram showed a 7x3mm thrombus at the junction of the SVC/RA 
(Figure 3) corresponding to the position of the tip of the previous PICC.   
     
Figure 3. Subcostal sagittal view demonstrating a 7 x 4 mm thrombus (Th) at the junction of the superior 
vena cava (SVC)-right atrium (RA). 
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A PICC was inserted 1 cm proximal to the thrombus and tissue type plasminogen activator (t-
PA) was administered at 0.2 mg/kg/hour. After 36 hours of t-PA administration, the thrombus 
measured 3x2mm.  The t-PA was discontinued and low-molecular-weight heparin (LMWH) was 
begun at 2mg/kg SQ q12hours and adjusted to achieve target anti-factor Xa levels of 0.5-1.0 
units/ml.  No excess bleeding was noted except at venipuncture sites and this was controlled with 
pressure. Coagulation studies returned to normal.  Head ultrasounds showed no intraventricular 
bleeding prior to or after t-PA administration.  On day of life 25 the thrombus measured 1x1mm 
and the chest x-ray was clear of infiltrates.  The LMWH was discontinued.  All bacterial, fungal 
and viral cultures were negative and antibiotics were stopped after 72 hours.  The infant was 
discharged home on day of life 86 weighing 1800 grams with resolution of the thrombus by 
echocardiogram.  Laboratory evaluation at 4 months of age for prothrombotic disorders 
including Factor V Leiden, protein S, protein C, antithrombin, and prothrombin G20210A were 
negative. 
 
Discussion 
The frequency of PE in the first 30 days of life is unknown, but likely underestimated because 
clinical features are often masked by a primary respiratory illness. In a review of autopsy cases 
of PE in childhood, the antemortem diagnosis was considered in only one third of patients.[4] 
PE in the neonate can be asymptomatic, mimic congenital heart disease, or present with 
respiratory failure, right heart failure, or persistent pulmonary hypertension of the newborn.[5-7]  
In addition, PE in children has been reported in association with DIC.[8]  We have presented two 
cases with divergent histories who both presented with sudden onset of respiratory failure from 
confirmed or suspected PE.  In Case One, despite clinical symptoms of venous obstruction, the 
diagnosis of PE was not considered until autopsy.  In Case Two, either pneumonia or pulmonary 
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hemorrhage was thought to be the most probable diagnosis until an echocardiogram revealed a 
large thrombus at the SVC/RA junction.  While the radiographic appearance of PE in the neonate 
is unknown, we speculate that the radiographic infiltrates in this case resulted from microthrombi 
similar to those seen at autopsy in Case One.  Both the thrombus and infiltrates resolved with 
thrombolytic therapy.   
89% of neonatal cases symptomatic venous thromboembolism (VTE) in the neonate are 
secondary to a CVL.[2]  Other reported risk factors include surgery and sepsis as seen in Case 
One, as well as other risks not seen in our cases including maternal diabetes, prolonged 
immobilization (with or without the use of paralytic drugs), polycythemia, asphyxia, 
hypotension, dehydration, closure of the ductus arteniosus, and hypercoagulable disorders.[1, 2, 9-
12, 23] 
The standard for diagnosis of VTE is angiography.  Doppler ultrasound is less invasive and can 
be performed at the bedside.  In one reported series, however, the accuracy of ultrasound was 
poor when compared to contrast venography in detecting asymptomatic thrombi.[13]  We presume 
Case One had a thrombus of the iliofemoral veins or IVC with the observed clinical symptoms of 
leg discoloration and swelling, as well as prominence of the superficial abdominal wall veins 
despite two negative ultrasound studies.  Because the thrombus found at autopsy in the 
pulmonary artery was well organized, we speculate that it likely formed over a prolonged period 
of time before terminally moving to obstruct the main pulmonary artery. 
PE has been diagnosed in neonates by echocardiography,[5-7, 9] cardiac catheterization, [14] V/Q 
scan,[6, 12] and CT angiography.[6] Cardiac catheterization with angiography is the gold standard 
for diagnosis of PE and also provides a means for treatment via thrombectomy.[15]   
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Optimal therapy for vascular thrombosis in the neonate has not been defined.[16]  Reported 
options include anticoagulation with heparin or LMWH, thrombolytic therapy with t-PA, 
surgery, and catheter-based embolectomy.[6, 7, 9, 12, 14, 15, 17-19]  We chose t-PA and LMWH because 
it is the most studied option.  t-PA has a short half-life, nonantigenic qualities, and local specific 
action on plasminogen bound fibrin.[20]  Catheter directed therapy has been shown to be superior 
to systemic t-PA therapy in the rabbit model of SVC thrombosis.[21] 
In a literature review of 94 cases of neonatal thrombus treated with t-PA, infusion rate ranged 
from 0.02-1mg/kg/hour, a duration of administration from ½-264 hours, and an initial bolus of 0-
0.75mg/kg.[22] Thrombolysis with concomitant heparin may be synergistic; however, whether 
LMWH or unfractionated heparin  (UFH) is better is still unclear.  The potential advantages of 
LMWH when compared with UFH include a more predictable pharmacokinetic profile, minimal 
monitoring, subcutaneous administration and potentially less bleeding and osteopenia.[6, 18] 
In summary, we recommend PE be considered in any previously stable neonate with sudden 
onset of respiratory failure and history of CVL.  We, like others, feel there is a need for a 
multicenter trial to evaluate the most effective therapeutic intervention for vascular thrombosis in 
the newborn. 
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